Newsletter | August 21, 2024

08.21.24 -- Innovation Advances In mRNA Medicine

SPONSOR

Custom Research-Grade mRNA Manufacturing Services

Research-grade mRNA can be used during the preclinical development of new vaccines, many types of therapeutics, and in gene editing and/or protein replacement applications. Let us assist you in designing your research-grade mRNA and benefit from our 15+ years’ experience in pre-clinical mRNA manufacturing. Read this technical note to find out how to choose your mRNA synthesis package based on your requirements. Download now!

FEATURED EDITORIAL

Collaboration Key To Going "Out On A Limb" For Nonviral mRNA Delivery

As the members of this panel at the World Vaccine Congress emphasized, they see great — and in some cases untapped — opportunities for collaboration to better advance nonviral delivery of a wide variety of RNA therapeutics. 

Innovation Advances In mRNA Medicine

The post-pandemic mRNA pipeline surge has led to a substantial investment in innovation. Let’s look at nonamplifying mRNA, saRNA, and circRNA.

INDUSTRY INSIGHTS

Navigating Challenges In Progressing Breakthrough RNA Therapeutics

RNA therapeutics hold immense promise for precision treatment, but their development faces challenges. A CDMO with adaptable platforms and flexible timelines can help reduce time and costs.

Benefits Of PCR-Based mRNA Manufacturing Processes

Learn about a proprietary polymerase chain reaction (PCR) solution that was developed to overcome the challenges associated with pDNA that applies the high accuracy of PCR to mRNA manufacturing.

Meeting Regulatory Requirements With Confidence

An outbreak of mycoplasma can halt a biopharmaceutical facility's production for months. Explore the impact of mycoplasma contamination and the most accurate and sensitive way to detect it.

Fit-For-Purpose Lipids Can Accelerate, Scale, And Improve RNA-LNP Drugs

Emerging biotech companies are investing in novel delivery capabilities to address different modalities' needs and extra-hepatic delivery. Explore steps to accelerate commercial nanomedicine delivery.

Establish Effective, Scalable Drug Safety Ops Across Multiple Vendors

Numerous factors impact a drug safety program, but proper management of three key elements drives success while creating a scalable drug safety model.

An Introduction And Brief History Of mRNA-LNPs

With adjustable components and increased stability during bloodstream circulation, LNPs are significantly advancing drug development and delivery, particularly for mRNA vaccines.

SPONSOR